GEMAROMA Gem Aromatics Q3 FY26 results (Oct–Dec 2025) and concall
GEM Aromatics reported a mixed Q3 FY26, with consolidated revenue at INR 78.9 crores and a net loss of INR 5 crores, primarily due to higher depreciation from the newly commissioned Dahej facility. However, gross and EBITDA margins saw significant quarter-on-quarter improvement, reaching 23% and 8.9% respectively. The company remains optimistic about its long-term growth, targeting INR 1,050-1,100 crores revenue by FY28 with 16-18% EBITDA margins, driven by the Dahej facility's ramp-up and product diversification despite ongoing external headwinds.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue down 18.5%, net profit down 166.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 112 | 97 | 202 | 88 | 90 −20% | 79 −19% |
| EBITDA | 15 | 13 | 46 | 15 | 3 −80% | 7 −46% |
| Net profit | 10 | 7 | 28 | 8 | -3 −126% | -5 −167% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
